Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000702072 | SCV000830906 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2023-12-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002386251 | SCV002671674 | uncertain significance | Cardiovascular phenotype | 2022-09-12 | criteria provided, single submitter | clinical testing | The p.V415M variant (also known as c.1243G>A), located in coding exon 8 of the FLNC gene, results from a G to A substitution at nucleotide position 1243. The valine at codon 415 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003144557 | SCV003833084 | uncertain significance | not provided | 2022-06-07 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV004555593 | SCV005044704 | uncertain significance | Hypertrophic cardiomyopathy 26 | criteria provided, single submitter | clinical testing |